{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:38:07Z","timestamp":1794209887881,"version":"4.8.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Although current guidelines highlight the need for earlier screening in women at increased risk of breast cancer in China, data on risk-adapted starting ages of screening are limited.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To explore the risk-adapted starting age of breast cancer screening in China, with comprehensive consideration of breast cancer risk factors.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n A multicenter community-based cohort study was conducted under the framework of the Cancer Screening Program in Urban China. Data were collected from January 1, 2013, to December 31, 2018, for unscreened community-dwelling women aged 40 to 74 years without a history of cancer, kidney dysfunction, or severe heart, brain, or lung disease. Data analysis was performed from October 1, 2021, to August 16, 2022.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Baseline characteristics associated with breast cancer, including first-degree family history of breast cancer, benign breast disease, breastfeeding, age at menarche, and body mass index.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Outcomes included breast cancer diagnosis and age at diagnosis. Risk-adapted starting age of screening was defined as the age at which women with different levels of breast cancer risk attained a 10-year cumulative risk level similar to women aged 50 years in the general population.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of the 1\u202f549\u202f988 women enrolled in this study, 3895 had breast cancer (median follow-up, 4.47 [IQR, 3.16-6.35] years). Participants were divided into different risk groups according to breast cancer risk scores (driven by risk factors including first-degree family history of breast cancer, benign breast disease, breastfeeding, age at menarche, and body mass index). Using the 10-year cumulative risk of breast cancer at age 50 years in the general population as a benchmark (2.65% [95% CI, 2.50%-2.76%]), the optimal starting age of screening for women with high, medium, or low risk of breast cancer was identified as 43, 48, or after 55 years, respectively. An online calculator was developed to calculate an individual\u2019s optimal starting age of screening.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n This study identifies the risk-adapted starting age of breast cancer screening based on the principle of equal management of equal risks, which may inform updates of current screening guidelines.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2022.41441","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T11:01:41Z","timestamp":1668078101000},"page":"e2241441","source":"Crossref","is-referenced-by-count":25,"title":["Use of Breast Cancer Risk Factors to Identify Risk-Adapted Starting Age of Screening in China"],"prefix":"10.1001","volume":"5","author":[{"given":"Yadi","family":"Zheng","sequence":"first","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesi","family":"Dong","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Qin","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Xu","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cao","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfa","family":"Xia","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Yu","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Luo","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Chen","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Li","sequence":"additional","affiliation":[{"name":"Office of Cancer Screening, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"},{"name":"Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Jiangsu Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"He","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"issue":"3","key":"zoi221170r1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.v71.3","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"zoi221170r2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jncc.2022.02.002","article-title":"Cancer incidence and mortality in China, 2016.","volume":"2","author":"Zheng","year":"2022","journal-title":"J Nat Cancer Center"},{"issue":"4","key":"zoi221170r3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.7326\/M15-0969","article-title":"Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 U.S. Preventive Services Task Force recommendation.","volume":"164","author":"Nelson","year":"2016","journal-title":"Ann Intern Med"},{"issue":"11","key":"zoi221170r4","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1038\/bjc.2013.257","article-title":"Breast cancer screening: time to target women at risk.","volume":"108","author":"Hall","year":"2013","journal-title":"Br J Cancer"},{"issue":"10","key":"zoi221170r5","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/bjc.2011.118","article-title":"Polygenic susceptibility to prostate and breast cancer: implications for personalised screening.","volume":"104","author":"Pashayan","year":"2011","journal-title":"Br J Cancer"},{"issue":"1","key":"zoi221170r6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jamaoncol.2019.3820","article-title":"Toward risk-stratified breast cancer screening: considerations for changes in screening guidelines.","volume":"6","author":"Gierach","year":"2020","journal-title":"JAMA Oncol"},{"issue":"12","key":"zoi221170r7","first-page":"1645","article-title":"Meta-analysis of breast cancer risk factors in Chinese women.","volume":"28","author":"Zheng","year":"2012","journal-title":"Chin J Publ Health"},{"issue":"10","key":"zoi221170r8","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H","article-title":"Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial.","volume":"75","author":"Tabar","year":"1995","journal-title":"Cancer"},{"issue":"11","key":"zoi221170r9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1470-2045(12)70425-4","article-title":"Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies.","volume":"13","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2012","journal-title":"Lancet Oncol"},{"issue":"3","key":"zoi221170r10","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s10549-012-1985-9","article-title":"Family history and risk of breast cancer: Nurses\u2019 Health Study.","volume":"133","author":"Colditz","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"zoi221170r11","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/cncr.33456","article-title":"Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: a nationwide cohort study.","volume":"127","author":"Mukama","year":"2021","journal-title":"Cancer"},{"issue":"11","key":"zoi221170r12","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1001\/jamaoncol.2018.1901","article-title":"Cost-effectiveness and benefit-to-harm ratio of risk-stratified screening for breast cancer: a life-table model.","volume":"4","author":"Pashayan","year":"2018","journal-title":"JAMA Oncol"},{"issue":"8","key":"zoi221170r13","doi-asserted-by":"crossref","first-page":"e1027","DOI":"10.1016\/S2214-109X(20)30215-1","article-title":"Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study.","volume":"8","author":"Heer","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"3","key":"zoi221170r14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10549-018-5042-1","article-title":"Trends in stage at diagnosis for young breast cancer patients in the United States.","volume":"173","author":"DeSantis","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"7564","key":"zoi221170r16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/bmj.333.7564.362","article-title":"Overweight and obesity in China.","volume":"333","author":"Wu","year":"2006","journal-title":"BMJ"},{"issue":"1","key":"zoi221170r18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jamaoncol.2019.3876","article-title":"Risk-adapted starting age of screening for relatives of patients with breast cancer.","volume":"6","author":"Mukama","year":"2020","journal-title":"JAMA Oncol"},{"issue":"4","key":"zoi221170r19","first-page":"357","article-title":"[China guideline for the screening and early detection of female breast cancer (2021, Beijing)].","volume":"43","author":"He","year":"2021","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"5","key":"zoi221170r21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B","article-title":"Family history and the risk of breast cancer: a systematic review and meta-analysis.","volume":"71","author":"Pharoah","year":"1997","journal-title":"Int J Cancer"},{"issue":"4","key":"zoi221170r22","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/jamainternmed.2017.8642","article-title":"Family history and breast cancer risk among older women in the Breast Cancer Surveillance Consortium Cohort.","volume":"178","author":"Braithwaite","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"3","key":"zoi221170r23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa044383","article-title":"Benign breast disease and the risk of breast cancer.","volume":"353","author":"Hartmann","year":"2005","journal-title":"N Engl J Med"},{"issue":"7","key":"zoi221170r24","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1007\/s00330-020-07490-5","article-title":"Breast density, benign breast disease, and risk of breast cancer over time.","volume":"31","author":"Rom\u00e1n","year":"2021","journal-title":"Eur Radiol"},{"issue":"10017","key":"zoi221170r25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(15)01024-7","article-title":"Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect.","volume":"387","author":"Victora","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"zoi221170r26","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1093\/annonc\/mdv379","article-title":"Breastfeeding and breast cancer risk by receptor status\u2014a systematic review and meta-analysis.","volume":"26","author":"Islami","year":"2015","journal-title":"Ann Oncol"},{"issue":"12","key":"zoi221170r27","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1038\/s41416-021-01540-5","article-title":"Associations between obesity, metabolic health, and the risk of breast cancer in East Asian women.","volume":"125","author":"Park","year":"2021","journal-title":"Br J Cancer"},{"key":"zoi221170r28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejca.2019.10.011","article-title":"Risk-tailored starting age of breast cancer screening based on women\u2019s reproductive profile: a nationwide cohort study.","volume":"124","author":"Mukama","year":"2020","journal-title":"Eur J Cancer"},{"issue":"5","key":"zoi221170r30","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/jjco\/hyw008","article-title":"The Japanese Guidelines for Breast Cancer Screening.","volume":"46","author":"Hamashima","year":"2016","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"zoi221170r32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/bcr1829","article-title":"Mammographic density, breast cancer risk and risk prediction.","volume":"9","author":"Vachon","year":"2007","journal-title":"Breast Cancer Res"},{"issue":"3","key":"zoi221170r33","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10549-014-2901-2","article-title":"Mammographic density\u2014a review on the current understanding of its association with breast cancer.","volume":"144","author":"Huo","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"9310","key":"zoi221170r34","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(02)08020-0","article-title":"Long-term effects of mammography screening: updated overview of the Swedish randomised trials.","volume":"359","author":"Nystr\u00f6m","year":"2002","journal-title":"Lancet"},{"issue":"256","key":"zoi221170r35","doi-asserted-by":"crossref","first-page":"n256","DOI":"10.1136\/bmj.n256","article-title":"Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai.","volume":"372","author":"Mittra","year":"2021","journal-title":"BMJ"},{"key":"zoi221170r15","volume-title":"China Cancer Registry Annual Report 2019","author":"He","year":"2021"},{"key":"zoi221170r17","volume-title":"Cancer Epidemiology: Principles and Methods","author":"dos Santos Silva","year":"1999"},{"key":"zoi221170r29","volume-title":"China Population Census Yearbook 2020","author":"Office of the Leading Group of the State Council for the Seventh National Population Census","year":"2022"},{"key":"zoi221170r20","unstructured":"National Cancer Center. Online calculator for risk-adapted starting age of breast cancer screening. Accessed August 16, 2022. http:\/\/cancerrc.ncsis.org.cn\/#\/utilshome"},{"key":"zoi221170r31","unstructured":"National Comprehensive Cancer Network. Breast cancer screening and diagnosis. Accessed May 29, 2022. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast-screening.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2798246\/zheng_2022_oi_221170_1667310001.0538.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T11:02:04Z","timestamp":1668078124000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2798246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.41441","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]}}}